Company news

OncoSil Medical Ltd news in 2024

OncoSil Medical Ltd's news releases, calls and decks from 2024, newest first.

View company

Oncosil completes $1 million Share Purchase Plan (SPP)

December 12, 2024

Prospectus 2024 Share Purchase Plan (SPP) Offer

November 5, 2024

OSL completes $7 M Placement and announces $1 M SPP

October 27, 2024

G-BA Approval received for OncoSil Device

October 23, 2024

Appendix 4E Preliminary Financial Report

August 29, 2024

Successful Treatment with OncoSil Device in Turkiye

August 15, 2024

Australian institution to invest $2.7 million in OSL

July 24, 2024

$5.3 million raised under Entitlement Offer

May 2, 2024

1st Study in Man Increases Pancreatic Tumor Vascularity

April 30, 2024

First patient treated with OncoSil device in Turkiye

April 15, 2024

First patient treated in the UK for the TRIPP-FXX study

April 11, 2024

First Austria-based treatments utilising the OncoSil device

April 4, 2024

Prospectus - Entitlement Offer

March 24, 2024

Placement and Entitlement Offer to raise up to $7.1 million

March 19, 2024

84 German hospitals can negotiate fee for Oncosil device

January 31, 2024

Decks in 2024